221 related articles for article (PubMed ID: 32897042)
1. Development of a Tau-Targeted Drug Delivery System Using a Multifunctional Nanoscale Metal-Organic Framework for Alzheimer's Disease Therapy.
Zhao J; Yin F; Ji L; Wang C; Shi C; Liu X; Yang H; Wang X; Kong L
ACS Appl Mater Interfaces; 2020 Oct; 12(40):44447-44458. PubMed ID: 32897042
[TBL] [Abstract][Full Text] [Related]
2. Tau-Targeted Multifunctional Nanocomposite for Combinational Therapy of Alzheimer's Disease.
Chen Q; Du Y; Zhang K; Liang Z; Li J; Yu H; Ren R; Feng J; Jin Z; Li F; Sun J; Zhou M; He Q; Sun X; Zhang H; Tian M; Ling D
ACS Nano; 2018 Feb; 12(2):1321-1338. PubMed ID: 29364648
[TBL] [Abstract][Full Text] [Related]
3. Controllable Synthesis of a Smart Multifunctional Nanoscale Metal-Organic Framework for Magnetic Resonance/Optical Imaging and Targeted Drug Delivery.
Gao X; Zhai M; Guan W; Liu J; Liu Z; Damirin A
ACS Appl Mater Interfaces; 2017 Feb; 9(4):3455-3462. PubMed ID: 28079361
[TBL] [Abstract][Full Text] [Related]
4. Highly efficient Fenton and enzyme-mimetic activities of NH
He J; Zhang Y; Zhang X; Huang Y
Sci Rep; 2018 Mar; 8(1):5159. PubMed ID: 29581533
[TBL] [Abstract][Full Text] [Related]
5. Tau protein aggregation in Alzheimer's disease: An attractive target for the development of novel therapeutic agents.
Jouanne M; Rault S; Voisin-Chiret AS
Eur J Med Chem; 2017 Oct; 139():153-167. PubMed ID: 28800454
[TBL] [Abstract][Full Text] [Related]
6. Methylene Blue Inhibits Formation of Tau Fibrils but not of Granular Tau Oligomers: A Plausible Key to Understanding Failure of a Clinical Trial for Alzheimer's Disease.
Soeda Y; Saito M; Maeda S; Ishida K; Nakamura A; Kojima S; Takashima A
J Alzheimers Dis; 2019; 68(4):1677-1686. PubMed ID: 30909223
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of methylene blue nanoparticles for Alzheimer's disease and other tauopathies.
Jinwal UK; Groshev A; Zhang J; Grover A; Sutariya VB
Curr Drug Deliv; 2014; 11(4):541-50. PubMed ID: 24237400
[TBL] [Abstract][Full Text] [Related]
8. Antibody-directed metal-organic framework nanoparticles for targeted drug delivery.
Cherkasov VR; Mochalova EN; Babenyshev AV; Rozenberg JM; Sokolov IL; Nikitin MP
Acta Biomater; 2020 Feb; 103():223-236. PubMed ID: 31843718
[TBL] [Abstract][Full Text] [Related]
9. Metal-organic frameworks, NH
Kim SN; Park CG; Huh BK; Lee SH; Min CH; Lee YY; Kim YK; Park KH; Choy YB
Acta Biomater; 2018 Oct; 79():344-353. PubMed ID: 30134206
[TBL] [Abstract][Full Text] [Related]
10. Hyperphosphorylated tau aggregation and cytotoxicity modulators screen identified prescription drugs linked to Alzheimer's disease and cognitive functions.
Liu M; Dexheimer T; Sui D; Hovde S; Deng X; Kwok R; Bochar DA; Kuo MH
Sci Rep; 2020 Oct; 10(1):16551. PubMed ID: 33024171
[TBL] [Abstract][Full Text] [Related]
11. Customized Intranasal Hydrogel Delivering Methylene Blue Ameliorates Cognitive Dysfunction against Alzheimer's Disease.
Liu Y; Tan Y; Cheng G; Ni Y; Xie A; Zhu X; Yin C; Zhang Y; Chen T
Adv Mater; 2024 May; 36(19):e2307081. PubMed ID: 38395039
[TBL] [Abstract][Full Text] [Related]
12. Shedding Light on Alzheimer's β-Amyloidosis: Photosensitized Methylene Blue Inhibits Self-Assembly of β-Amyloid Peptides and Disintegrates Their Aggregates.
Lee BI; Suh YS; Chung YJ; Yu K; Park CB
Sci Rep; 2017 Aug; 7(1):7523. PubMed ID: 28790398
[TBL] [Abstract][Full Text] [Related]
13. "Lest we forget you--methylene blue...".
Schirmer RH; Adler H; Pickhardt M; Mandelkow E
Neurobiol Aging; 2011 Dec; 32(12):2325.e7-16. PubMed ID: 21316815
[TBL] [Abstract][Full Text] [Related]
14. Label-Free Bimetallic In Situ-Grown 3D Nickel-Foam-Supported NH
Palanisamy S; Senthil Raja D; Subramani B; Wu TH; Wang YM
ACS Appl Mater Interfaces; 2020 Jul; 12(29):32468-32476. PubMed ID: 32578973
[TBL] [Abstract][Full Text] [Related]
15. The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.
Fan SJ; Huang FI; Liou JP; Yang CR
Cell Death Dis; 2018 May; 9(6):655. PubMed ID: 29844403
[TBL] [Abstract][Full Text] [Related]
16. Nanoscale metal-organic frameworks for biomedical imaging and drug delivery.
Della Rocca J; Liu D; Lin W
Acc Chem Res; 2011 Oct; 44(10):957-68. PubMed ID: 21648429
[TBL] [Abstract][Full Text] [Related]
17. Outstanding Drug-Loading/Release Capacity of Hollow Fe-Metal-Organic Framework-Based Microcapsules: A Potential Multifunctional Drug-Delivery Platform.
Cui R; Zhao P; Yan Y; Bao G; Damirin A; Liu Z
Inorg Chem; 2021 Feb; 60(3):1664-1671. PubMed ID: 33434431
[TBL] [Abstract][Full Text] [Related]
18. Tau-Targeted Multifunctional Nanoinhibitor for Alzheimer's Disease.
Zhu L; Xu L; Wu X; Deng F; Ma R; Liu Y; Huang F; Shi L
ACS Appl Mater Interfaces; 2021 May; 13(20):23328-23338. PubMed ID: 33999598
[TBL] [Abstract][Full Text] [Related]
19. Carbon Dots Embedded Magnetic Nanoparticles @Chitosan @Metal Organic Framework as a Nanoprobe for pH Sensitive Targeted Anticancer Drug Delivery.
Chowdhuri AR; Singh T; Ghosh SK; Sahu SK
ACS Appl Mater Interfaces; 2016 Jul; 8(26):16573-83. PubMed ID: 27305490
[TBL] [Abstract][Full Text] [Related]
20. The multifunctional dopamine D
Ziu I; Rettig I; Luo D; Dutta A; McCormick TM; Wu C; Martic S
Bioorg Med Chem; 2020 Sep; 28(18):115667. PubMed ID: 32828429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
